Management of Staphylococcus Bacteremia
Diagnosis and Assessment
- The Infectious Diseases Society of America recommends obtaining follow-up blood cultures 2-4 days after initial positive cultures to document clearance, and conducting a thorough assessment to identify the source and extent of infection, including classification of the bacteremia as either uncomplicated or complicated 1, 2
- Echocardiography should be performed to rule out endocarditis, with transesophageal echocardiography (TEE) preferred in adults due to superior sensitivity, as recommended by the American Heart Association 1, 3, 4
- Bacteremia is classified as uncomplicated if hemocultures are negative in <48 hours, defervescence occurs in <72 hours, there are no metastatic foci, and no endocarditis, whereas complicated bacteremia is defined by positive hemocultures >48 hours, persistent fever, signs of metastatic infection, implanted prostheses, or a history of injectable drug use, as recommended by the Infectious Diseases Society of America 1, 5
Treatment
- First-line treatment for Staphylococcus aureus bacteremia includes cefazolin IV or anti-staphylococcal penicillin for MSSA, and vancomycin IV or daptomycin 6 mg/kg/day IV for MRSA, with a duration of 2 weeks for uncomplicated cases and 4-6 weeks for complicated cases, as recommended by the Infectious Diseases Society of America 2, 1, 5
- Combination therapy with daptomycin + ceftaroline may be considered for persistent MRSA bacteremia, as recommended by the Infectious Diseases Society of America 1
- The American College of Cardiology recommends against the addition of gentamicin to vancomycin for bacteremia or native valve endocarditis, due to lack of benefit and potential toxicity 2
- For children with S. aureus bacteremia, the Infectious Diseases Society of America recommends IV vancomycin, with alternative options including clindamycin and linezolid, based on susceptibility patterns and patient factors 2
Source Control
- Infected intravascular catheters should be removed immediately, as recommended by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America 3
- Abscesses and purulent collections should be drained, and surgical debridement should be performed when necessary, to achieve source control and prevent complications, as recommended by the Infectious Diseases Society of America 2, 1, 6
- Infected prosthetic material should be removed when feasible 3
Monitoring and Follow-up
- Follow-up blood cultures should be obtained 2-4 days after initial positive cultures and as needed thereafter, to monitor response to treatment and detect potential complications, as recommended by the Infectious Diseases Society of America 2, 5
- Patients should be monitored for signs of metastatic infection, including endocarditis, septic arthritis, vertebral osteomyelitis, and epidural abscess 5
- If fever or bacteremia persists ≥3 days after catheter removal and appropriate antibiotics, obtain additional TEE to rule out infective endocarditis, as recommended by the American Heart Association 3
- Transitioning to oral antibiotics after ≥10 days of IV therapy may be a viable alternative, but oral therapy for less than 14 days is associated with a significant risk of relapse, as recommended by the Infectious Diseases Society of America 5
- Patient evaluation for transition to oral antibiotics includes assessing whether the patient is a candidate, selecting an appropriate oral antibiotic, determining the total duration of therapy, and monitoring response and adverse effects, as recommended by the Infectious Diseases Society of America 1, 5, 7, 2
- Oral antibiotics such as linezolid, clindamycin, trimethoprim-sulfamethoxazole (TMP-SMX), and doxycycline may be used for step-down therapy, with the choice of antibiotic depending on the susceptibility of the isolate and the clinical condition of the patient, as recommended by the Infectious Diseases Society of America 7
Prevention of Complications
- Inadequate source control, insufficient treatment duration, overlooking metastatic foci, ignoring antibiotic resistance, and failure to obtain follow-up blood cultures can lead to treatment failure and complications, as recommended by the Infectious Diseases Society of America 1
- The Infectious Diseases Society of America recommends treatment of Staphylococcus aureus bacteremia with intravenous antibiotics, such as vancomycin or daptomycin for MRSA, or cefazolin/anti-staphylococcal penicillin for MSSA, for at least 2 weeks in uncomplicated cases and 4-6 weeks in complicated cases, along with prompt removal of infected catheters and source control 2, 3